doripenem has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, T; Katsube, T; Matsumoto, S; Matsuo, Y; Wajima, T | 1 |
| Boonpeng, A; Chaijamorn, W; Charoensareerat, T; Pattharachayakul, S; Puchsaka, P; Pummangura, C; Srisawat, N | 1 |
| Cheatham, SC; Chung, EK; Fleming, MR; Kays, MB | 1 |
3 other study(ies) available for doripenem and Body Weight
| Article | Year |
|---|---|
Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen Assessment.
Topics: Adolescent; Anti-Bacterial Agents; Biological Variation, Population; Body Weight; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Computer Simulation; Doripenem; Drug Administration Schedule; Drug Dosage Calculations; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Multicenter Studies as Topic; Pneumococcal Infections; Sex Factors; Streptococcus pneumoniae | 2019 |
Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Body Weight; Continuous Renal Replacement Therapy; Critical Illness; Doripenem; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Carbapenems; Doripenem; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Obesity | 2017 |